{
    "Trade/Device Name(s)": [
        "CellSearch\u2122M Circulating Tumor Cell Kit",
        "CellSearchTM Circulating Tumor Cell Kit"
    ],
    "Submitter Information": "Veridex, LLC",
    "510(k) Number": "K062013",
    "Predicate Device Reference 510(k) Number(s)": [
        "K050245"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NQI"
    ],
    "Summary Letter Date": "July 14, 2006",
    "Summary Letter Received Date": "July 17, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.6020"
    ],
    "Regulation Name(s)": [
        "Immunomagnetic Circulating Cancer Cell Selection and Enumeration System"
    ],
    "Analyte Class(es)": [
        "cancer molecular",
        "immunology"
    ],
    "Analyte(s)": [
        "Circulating tumor cells of epithelial origin (CD45-, EpCAM+, cytokeratins 8, 18+, and/or 19+)"
    ],
    "Specimen Type(s)": [
        "Whole Blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "CellTracks\u00ae AutoPrep System",
        "CellTracks\u00ae Analyzer II",
        "CellSpotter\u00ae Analyzer",
        "MagNest\u00ae cell presentation device"
    ],
    "Method(s)/Technology(ies)": [
        "Immunomagnetic cell selection",
        "Immunofluorescence",
        "Enumeration"
    ],
    "Methodologies": [
        "Immunomagnetic separation",
        "Fluorescent labeling",
        "Automated image analysis"
    ],
    "Submission Type(s)": [
        "Kit",
        "System",
        "Reagent",
        "Cartridge",
        "Analyzer"
    ],
    "Document Summary": "FDA 510(k) summary for CellSearch Circulating Tumor Cell Kit using immunomagnetic separation and fluorescence to enumerate circulating tumor cells in whole blood for monitoring metastatic breast cancer.",
    "Indications for Use Summary": "Intended for enumeration of circulating tumor cells of epithelial origin in whole blood; presence of CTC is associated with decreased progression free and overall survival in metastatic breast cancer patients; test is used as an aid in monitoring these patients with serial testing in conjunction with other clinical methods.",
    "fda_folder": "Immunology"
}